» Articles » PMID: 37635248

MiRNA-related Metastasis in Oral Cancer: Moving and Shaking

Abstract

Across the world, oral cancer is a prevalent tumor. Over the years, both its mortality and incidence have grown. Oral cancer metastasis is a complex process involving cell invasion, migration, proliferation, and egress from cancer tissue either by lymphatic vessels or blood vessels. MicroRNAs (miRNAs) are essential short non-coding RNAs, which can act either as tumor suppressors or as oncogenes to control cancer development. Cancer metastasis is a multi-step process, in which miRNAs can inhibit or stimulate metastasis at all stages, including epithelial-mesenchymal transition, migration, invasion, and colonization, by targeting critical genes in these pathways. On the other hand, long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs), two different types of non-coding RNAs, can regulate cancer metastasis by affecting gene expression through cross-talk with miRNAs. We reviewed the scientific literature (Google Scholar, Scopus, and PubMed) for the period 2000-2023 to find reports concerning miRNAs and lncRNA/circRNA-miRNA-mRNA networks, which control the spread of oral cancer cells by affecting invasion, migration, and metastasis. According to these reports, miRNAs are involved in the regulation of metastasis pathways either by directly or indirectly targeting genes associated with metastasis. Moreover, circRNAs and lncRNAs can induce or suppress oral cancer metastasis by acting as competing endogenous RNAs to inhibit the effect of miRNA suppression on specific mRNAs. Overall, non-coding RNAs (especially miRNAs) could help to create innovative therapeutic methods for the control of oral cancer metastases.

Citing Articles

Immunoregulatory role of exosomal circRNAs in the tumor microenvironment.

Lv C, Chen J, Wang Y, Lin Y Front Oncol. 2025; 15:1453786.

PMID: 40034598 PMC: 11872884. DOI: 10.3389/fonc.2025.1453786.


Distant metastasis of oral squamous cell carcinoma: immune escape mechanism and new perspectives on treatment.

He L, Wan M, Yang X, Meng H Discov Oncol. 2025; 16(1):257.

PMID: 40024975 PMC: 11872995. DOI: 10.1007/s12672-025-01997-3.


Bile's Hidden Weapon: Modulating the Microbiome and Tumor Microenvironment.

Saadh M, Ahmed H, Al-Hussainy A, Kaur I, Kumar A, Chahar M Curr Microbiol. 2024; 82(1):25.

PMID: 39614901 DOI: 10.1007/s00284-024-04004-0.


Non-coding RNAs in oral cancer: Emerging biomarkers and therapeutic frontier.

Hashemi M, Khoushab S, Hobabi Aghmiuni M, Anaraki S, Alimohammadi M, Taheriazam A Heliyon. 2024; 10(21):e40096.

PMID: 39583806 PMC: 11582460. DOI: 10.1016/j.heliyon.2024.e40096.


A new perspective on diagnostic strategies concerning the potential of saliva-based miRNA signatures in oral cancer.

Prasad M, Sekar R, Priya M, Varma S, Karobari M Diagn Pathol. 2024; 19(1):147.

PMID: 39548527 PMC: 11568613. DOI: 10.1186/s13000-024-01575-1.


References
1.
DSouza S, Addepalli V . Preventive measures in oral cancer: An overview. Biomed Pharmacother. 2018; 107:72-80. DOI: 10.1016/j.biopha.2018.07.114. View

2.
Noguti J, DE Moura C, Protasio Pacheco de Jesus G, da Silva V, Hossaka T, Oshima C . Metastasis from oral cancer: an overview. Cancer Genomics Proteomics. 2012; 9(5):329-35. View

3.
Okura M, Aikawa T, Yoshimura Sawai N, Iida S, Kogo M . Decision analysis and treatment threshold in a management for the N0 neck of the oral cavity carcinoma. Oral Oncol. 2009; 45(10):908-11. DOI: 10.1016/j.oraloncology.2009.03.013. View

4.
Sankunny M, Parikh R, Lewis D, Gooding W, Saunders W, Gollin S . Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss. Genes Chromosomes Cancer. 2013; 53(2):129-43. PMC: 4216593. DOI: 10.1002/gcc.22125. View

5.
Patel S, Carpenter W, Tyree S, Couch M, Weissler M, Hackman T . Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol. 2011; 29(11):1488-94. DOI: 10.1200/JCO.2010.31.7883. View